It's the Institutions, Stupid! Why U.S. Health Care Expenditure Is so Different from Canada's

References

• Aaron, Craig and Taylor Lincoln. "The Other Drug War 2003: Drug Companies Deploy an Army of 675 Lobbyists to Protect Profits." Washington, DC: Public Citizen's Congress Watch, 2003.
   Google Scholar
• Adkisson, Richard V. "The Original Institutionalist Perspective on Economy and its Place in a Pluralist Paradigm." Paper presented at the Annual Meeting of the Association for Institutional Thought. Reno, NV, April 15, 2010.
   Google Scholar
• Alvarez Michael R., Nathaniel Beck, Geoffrey Garrett, Jonathan N. Katz and Peter Lange. "Government Partisanship, Labor Organization and Macro-economic Performance." American Political Science Review 85, 2 (1991): 539-556.
   Google Scholar
• American Medical Association (AMA). "Physicians' Political Communications with Patients and their Families." Council on Ethical and Judicial Affairs (CEJA) report 2-I-98. Washington, DC: AMA; 1998. Available at www.ama-assn.org
   Google Scholar
• American Medical Association (AMA). "Code of Medical Ethics; The World's First National Codification of Professional Ethics." Washington, DC: AMA, 2007. Available at www.ama-assn.org
   Google Scholar
• Anderson, Gerard F., Uwe E. Reinhardt, Peter S. Hussey and Varduhi Petrosyan. "It's the Prices, Stupid: Why the United States is so Different from Other Countries." Health Affairs 22, 1 (2003): 89-105.
   Google Scholar
• Angell, Marcia. "The Pharmaceutical Industry — To Whom Is It Accountable?" New England Journal of Medicine 342, 25 (2000): 1902-1904.
   Google Scholar
• Angell, Marcia. "Excess in Pharmaceutical Industry." Canadian Medical Association Journal 171, 12 (2004): 1451-1453.
   Google Scholar
• Angrisano, Carlos, Diana Farrel, Bob Kocher, Martha Laboissiere and Sara Parker. Accounting for the Cost of Health Care in the United States. Washington, DC: McKinsey Global Institute, 2007.
   Google Scholar
• Arrow, Kenneth J. "Uncertainty and the Welfare Economics of Medical Care." American Economic Review 53, 5 (1963): 941-973.
   Google Scholar
• Ayres, Clarence Edwin. Toward a Reasonable Society: the Values of Industrial Civilization. Austin: University of Texas Press, 1961.
   Google Scholar
• Balkin, Jack M. "The Constitutionality of the Individual Mandate for Health Insurance." New England Journal of Medicine 362, 6 (2010): 482-483.
   Google Scholar
• Beckel, Michael. "Big Labor Gave Big Support to Health Reform Supporters, Health Interests Lent More Support to Opponents." March 22, 2010a. Available at www.opensecrets.org
   Google Scholar
• Beckel, Michael. "Health Interests and Labor Groups Vied To Sway Blue Dog Democrats." March 31, 2010b. Available at www.opensecrets.org
   Google Scholar
• Beckel, Michael. "Public Option in National Spotlight, But Rarely in Details of Lobbying Reports." 24 February 2010c. Available at www.opensecrets.org
   Google Scholar
• Birnbaum, Jefffrey H. "Hill a Steppingstone to K Street for Some." Washington Post. July 27, 2005.
   Google Scholar
• Bureau of Labor Statistics (BLS). "Health Care, Spotlight on Statistics; 2009." 2009. Available at www.bls.gov
   Google Scholar
• Bureau of Labor Statistics (BLS). "Consumer Price Index; All Urban Consumers (CPI-U); US City Average; All Items." 2010. Available at www.bls.gov
   Google Scholar
• Boldrin, Michele and David K. Levine. "Rent-Seeking and Innovation." Journal of Monetary Economics 51, 1 (2004): 127-160.
   Google Scholar
• Boulding, Kenneth Ewart. The Economy of Love and Fear: A Preface to Grants Economics. Belmont, CA: Wadsworth, 1974.
   Google Scholar
• Bray, Mark and Jacques Rouillard. "Union Structure and Strategy in Australia and Canada." Labour History 71, November (1996): 198-238.
   Google Scholar
• The Center for Public Integrity. "Drug Industry Influence Timeline." Last update June 2008. Available at www.publicintegrity.org
   Google Scholar
• Center for Responsive Politics. "Influence & Lobbying: Industry Profiles; Health Professionals [respectively Pharmaceuticals/Health Products], Long-Term Contribution Trends." [2009a]. Available at www.opensecrets.org
   Google Scholar
• Center for Responsive Politics. "Influence & Lobbying: Lobbyists." [2009b]. Available at www.opensecrets.org
   Google Scholar
• Center for Responsive Politics. "Politicians & Elections." [2009c]. Available at www.opensecrets.org
   Google Scholar
• Commons, John R. Institutional Economics. New York: Macmillan, 1934.
   Google Scholar
• Corcoran, Terence. "The Right to Lobby." National Post. May 11, 2006.
   Google Scholar
• Danzon, Patricia. "The Frequency and Severity of Medical Malpractice Claims." Journal of Law & Economics 27, 1 (1984): 115-148.
   Google Scholar
• Dogan, Deniz. "Gezondheidshervormingen in de VS en de Invloed van de Farmaceutische Industrie." [Health Care Reforms and the Impact of the Pharmaceutical Industry]. Masters Thesis, Social and Institutional Economics. Utrecht: Utrecht University, 2007.
   Google Scholar
• Evans, Robert. "Health Reform: What ‘Business’ Is It of Business?" In Health Reform: Public Success Private Failure, edited by Daniel Drache and Terry Sullivan, pp. 25-47. London and New York: Routledge, 1999.
   Google Scholar
• Faulkner, Harold Underwood. American Economic History. Seventh edition. New York: Harper and Brothers, 1954.
   Google Scholar
• Federal Election Commission. Campaign Guide for Political Party Committees, 2009. Available at www.fec.gov
   Google Scholar
• Fox, Justin and Lawrence Rothenberg. "Influence without Bribes: A Non-Contracting Model of Campaign Giving and Policymaking." Working Paper. New Haven: Department of Political Science at Yale University, 2009. Available at http://pantheon.yale.edu/~jf398/
   Google Scholar
• Friesner, Dan. "Institutional Policy-Making in (In)Action: The Case of Pharmacy Ownership in North Dakotas." Journal of Economic Issues 43, 4 (2009): 1025-1042.
   Google Scholar
• Furlow, Bryant. "U.S. Health Reform: A Mixed Bag for Insurers and Drug Companies." Lancet Oncology 11, 5 (2010): 417-418.
   Google Scholar
• Gaynor, Martin. "What Do We Know About Competition and Quality in Health Care Markets?" NBER Working Paper 12301. Cambridge, MA: NBER 2006.
   Google Scholar
• Gaynor, Martin and William B. Vogt. "Antitrust and Competition in Health Care Markets." In Handbook of Health Economics, Volume 1B, edited by Anthony J. Culyer and Joseph P. Newhouse, pp. 1405-1487. Amsterdam: North-Holland Elsevier 2000.
   Google Scholar
• Givel, Michael S. and Stanton A. Glantz. "Tobacco Lobby Political Influence on US State Legislatures in the 1990s." Tobacco Control 10, 2 (2001): 124-1234.
   Google Scholar
• Groenewegen, John, Antoon Spithoven and Annette Van den Berg. Institutional Economics: An Introduction. Houndmills, UK and New York: Palgrave Macmillan, 2010.
   Google Scholar
• Hall, Edward T. Beyond Culture. Garden City, NY: Anchor Books 1977.
   Google Scholar
• Hartzband, Pamela and Jerome Groopman. "Money and the Changing Culture of Medicine." New England Journal of Medicine 360, 2 (2009): 1001-1003.
   Google Scholar
• Hayden, F. Gregory. "Values and Beliefs in a Sociotechnical Setting." Journal of Economic Issues 22, 2 (1988): 415-434.
   Google Scholar
• Hemerijck, Anton. "The Historical Contingencies of Dutch Corporatism." Thesis, Balliol College. Oxford: University of Oxford, 1992.
   Google Scholar
• Himmelstein, David U., Steffie Woolhandler and Sidney M. Wolfe. "Administrative Waste in the U.S. Health Care System in 2003: The Cost to the Nation, the States and the District of Columbia, with State-Specific Estimates of Potential Savings." Washington, DC: The Division of Social and Community Medicine, Department of Medicine; The Cambridge Hospital and Harvard Medical School, Cambridge MA; and The Public Citizen health Research Group: Washington, DC, 2003. Available at www.publiccitizen.org/documents/AdminWaste.pdf
   Google Scholar
• Hofstede, Gerard Hendrik. Culture and Organizations; Software of the Mind. London: HarperCollins Business, 1994.
   Google Scholar
• House, Robert J., Paul J. Hanges, Mansour Javidan, Peter W. Dorfman and Vipin Gupta. Culture, Leadership and Organizations: The GLOBE Study of 62 Societies. Thousand Oaks, CA, London and New Delphi: Sage Publications, 2004.
   Google Scholar
• Huo, Jingjing, Moira Nelson and John D. Stephens. "Decommodification and Activation in Social Democratic Policy: Resolving the Paradox." Journal of European Social Policy 18, 1 (2008): 5-20.
   Google Scholar
• Hurley, Jeremiah. "An Overview of the Normative Economics of the Health Sector." In Handbook of Health Economics, Volume 1A, edited by Anthony J. Culyer and Joseph P. Newhouse, pp. 56-118. Amsterdam: North-Holland Elsevier, 2000.
   Google Scholar
• Hutton, James and Mahmoud Watad. "Political Action Committees, ‘Soft’ Money, Foreign Contributions and US Politics: Lessons from the American Experience." Journal of Communication Management 3, 3 (1999): 293-302.
   Google Scholar
• Inglehart, John K. "Revisiting the Canadian Health Care System." New England Journal of Medicine 342, 26 (2000): 2007-2012.
   Google Scholar
• Josefson, Deborah. "U.S. Government Supports Maine Law to Curb Drug Prices." British Medical Journal 324, 7351 (2002): 1416.
   Google Scholar
• Kaufmann, Daniel and Pedro C. Vicente. "Legal Corruption." Second Draft. Working Paper. Washington, DC: World Bank, 2005. Available at http://web.worldbank.org
   Google Scholar
• Kirch, Darrell G. and David J. Vernon. "The Ethical Foundation of American Medicine: In Search of Social Justice." Journal of the American Medical Association 302, 14 (2009): 1482-1484.
   Google Scholar
• Kaiser Family Foundation (KKF). "Trends and Indicators in the Changing Health Care Marketplace; Exhibit 1.10: Per Enrollee Growth in Medicare Spending and Private Health Insurance Premiums (for Common Benefits), 1970-2004." Last updated August 2, 2006. Available at www.kff.org
   Google Scholar
• Lane, Jan Erik and Svante Ersson. The New Institutional Economics; Performance and Outcomes. New York: Routledge, 2000.
   Google Scholar
• Leffner, Keith B. "Arizona v. Maricopa County Medical Society: Maximum-Price Agreements in Markets with Insured Buyers." Supreme Court Economic Review 2 (1983): 187-211.
   Google Scholar
• [Lemieux.] "Lemieux Explains the Quebec Act." Toronto World. January 13, 1914.
   Google Scholar
• Lexchin, Joel. "Controlling Pharmaceutical Expenditures in Canada." In Health Reform; Public Success Private Failure, edited by Daniel Drache and Terry Sullivan, pp. 292-312. London and New York: Routledge, 1999.
   Google Scholar
• Lowery, David, Virginia Gray, Jennifer Benz, Mary Deason, Justin Kirkland and Jennifer Sykes. "Understanding the Relationship Between Health PACS and Health Lobbying in the American States." Publius: The Journal of Federalism 39, 1 (2009): 70-94.
   Google Scholar
• Mackey, Eva. The House of Difference: Cultural Politics and National Identity in Canada. London: Routledge, 1999.
   Google Scholar
• Mahoney, Christine. "Lobbying Success in the United States and the European Union." Journal of Public Policy 27, 1 (2007): 35-56.
   Google Scholar
• Matthews, Merrill. "Medicare's Hidden Administrative Costs: A Comparison of Medicare in the Private Sector." Alexandria, VA: Council for Affordable Health Insurance, 2006. Available at www.cahi.org/cahi_contents/resources/archive.asp
   Google Scholar
• McGuire, Thomwas G. "Physician Agency." In Handbook of Health Economics, Volume 1B, edited by Anthony J. Culyer and Joseph P. Newhouse, pp. 461-536. Amsterdam: North-Holland Elsevier, 2000.
   Google Scholar
• Medical Group Management Association (MGMA). Physician Compensation and Production Survey; 2004 Report Based on 2003 Data. Englewood, CO: Center for Research in Ambulatory Health Care Administration, 2004.
   Google Scholar
• Medical Group Management Association (MGMA). Physician Compensation and Production Survey; 2008 Report Based on 2007 Data. Englewood, CO: Center for Research in Ambulatory Health Care Administration, 2008.
   Google Scholar
• Mitka, Mike. "Rescinding Coverage." Journal of the American Medical Association 302, 6 (2009): 619.
   Google Scholar
• Neale, Walter C. "Institutions." Journal of Economic Issues 21, 3 (1987): 1177-1206.
   Google Scholar
• National Center for Health Statistics (NCHS). Health, United States, 2008; With Chartbook. Hyattsville, MD: NCHS, 2009.
   Google Scholar
• National Conference of State Legislatures (NCSL). "Prescription Drugs Laws in Maine-Archive Only." 2010. www.ncsl.org/default.aspx?tabid=14431
   Google Scholar
• Newhouse, John P. "Consumer-Directed Health Plans and the RAND Health Insurance Experiment." Health Affairs 23, 6 (2004): 107-113.
   Google Scholar
• Obama, Barack H. "Executive Order — Ethics Commitments by Executive Branch Personnel." January 21, 2009. Washington, DC: The White House, 2009. Available at www.whitehouse.gov
   Google Scholar
• Office of the Assistant Secretary for Planning and Evaluation. "Confronting the New Health Care Crisis: Improving Health Care Quality and Lowering Costs By Fixing Our Medical Liability System." Washington, DC: U.S. Department of Health and Human Services. 2002. Available at http://aspe.hhs.gov
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). Health Data 2005. Paris: OECD, Version 6, June 2005.
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). Health Statistics; Selected Data. Paris: OECD; Rheinberg: Data Services Information Statistical Databases, 2010.
   Google Scholar
• Peterson, Chris L. and Rachel Burton. "U.S. Health Care Spending: Comparison with Other OECD Countries." CRS Report for Congress. Order Code RL34175. Washington, DC: Congressional Research Service, 2007.
   Google Scholar
• Relman, Arnold. "The Health Reform We Need & Are Not Getting." New York Review of Books 56, 11 (2009).
   Google Scholar
• Sage, William M., David A. Hyman and Warren Greenbergage. "Why Competition Law Matters to Health Care Quality." Health Affairs 22, 2 (2003): 31-44.
   Google Scholar
• Santere, Rexford E. "Tracking Uninsurance and Inflation in the U.S. Health Economy." Working Paper 2007-5. 2007. Available at www.business.uconn.edu/healthcare/
   Google Scholar
• Sen, Amartya. "Health Care, Elsewhere: An Exchange; a Reply of Amartya Sen to John Dean's and Harold and Norman Kalant's Letters." New York Review of Books 56, 12 (2009): 49.
   Google Scholar
• Smith, Richard A. "Interest Group Influence in the U.S. Congress." Legislative Studies Quarterly 20, 1 (1995): 89-138.
   Google Scholar
• Spithoven, Antoon. "Why U.S. Health Care Expenditure and Ranking on Health Care Indicators Are so Different from Canada's." International Journal of Health Care Finance and Economics 9, 1 (2009): 1-24.
   Google Scholar
• Sullivan, Patrick. "CMA and Other Members of Lobby Group Develop Five-Point Plan for Canada's Health Care Future." Canadian Medical Association Journal 146, 4 (1992): 591-592.
   Google Scholar
• Thomson, Sarah and Elias Mossialos. What Are the Equity, Efficiency, Cost Containment and Choice Implications of Private Health-Care Funding in Western Europe? Copenhagen, WHO Regional Office for Europe (Health Evidence Network Report), 2004. Available at www.euro.who.int/Document/E83334.pdf
   Google Scholar
• Toews, Vic (President of the Treasury Board of Canada Secretariat). Office of the Registrar of Lobbyists 2006-2007; Departmental Performance Report. Treasury Board of Canada Secretariat, Ottowa, Canada, 2007. Available at www.tbs-sct.gc.ca
   Google Scholar
• Tomasky, Michael. "Washington: Will the Lobbyist Win?" New York Review of Books 56, 6 (2009a): 18-22.
   Google Scholar
• Tomasky, Michael. "Who Are the Blue Dogs?" New York Review of Books 56, 19 (2009b): 10, 12.
   Google Scholar
• Transparency International. "[2001 to 2009] Corruption Perceptions Index." 2010. www.transparency.org
   Google Scholar
• Trompenaars, Fons and Charles Hampden-Turner. Riding the Waves of Culture. Second Edition. London: Nicholas Brealey Publishing, 1999.
   Google Scholar
• U.S. House of Representatives Committee on Energy and Commerce. "Terminations of Individual Health Policies by Insurance Companies; Hearings - Subcommittee on Oversight and Investigations." June 16, 2009. Available at http://energycommerce.house.gov
   Google Scholar
• U.S. Senate Committee on Finance. America's Health Future Act of 2009. Report 111-89, United States Senate, October 19, 2009.
   Google Scholar
• Weissman, Joel S. and Judy Ann Bigby. "Massachusetts Health Care Reform — Near-Universal Coverage at What Cost?" New England Journal of Medicine 361, 21 (2009): 2012-2015.
   Google Scholar
• Wenzlow, Audra T., Dan Finkelstein, Ben Le Cook, Kathy Shepperson, Christine Yip and David Baugh. The Medicaid Analytic Extract Chartbook. Baltimore, MD: Centers for Medicare and Medicaid Services, 2007.
   Google Scholar
• Williamson, Oliver E. "Comparative Economic Organization." Administrative Science Quarterly 36, 2 (1991): 269-296.
   Google Scholar
• Zimmerman, Ilana. "Whose Interests Are PhRMA Protecting? A Look at Pharmaceutical Industry Lobbying." Corporate Examiner. Interfaith Center on Corporate Responsibility. Available at www.iccr.org
   Google Scholar